CLINICAL_TRIALS
withdrawal
· 2025-12-17
Clinical Trial Update: Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients [NA]
Summary
A clinical trial evaluating the efficacy and tolerability of fractional ablative Erbium laser for axillary scarring in hidradenitis suppurativa patients has bee…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Montefiore Medical Center | Conditions: Hidradenitis Suppurativa, Scarring | NA | Status: WITHDRAWN